Lang Sheng Investment
VC Fund
Shanghai, China
Lang Sheng Investment is a leading life science and big data investment firm in China committed to helping exceptional entrepreneurs build the next generation of great healthcare and big data companies.They invest across the healthcare and big data sectors with an emphasis on the venture stages of company development. With close to RMB600 millionunder management and the headquarters in Shanghai, Lang Sheng has built a team with strong investment expertise. Since the firm’s founding in 2010, they have invested in 23 companies in the life science and big data companies in China.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Lang Sheng Investment invests in
Stages Lang Sheng Investment invests in
Countries Lang Sheng Investment invests in
Investment Focus
Industry
- Health Care 5 (28%)
- Pharmaceutical 5 (28%)
- Medical 4 (22%)
- Biotechnology 4 (22%)
- Software 3 (17%)
Stage
- Series B 7 (39%)
- Series A 5 (28%)
- Series C 2 (11%)
- Seed 1 (6%)
- Angel 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Svision is a healthcare start-up that develops and produces high-end ophthalmic imaging equipment. | $43.1M / Series C / Mar 09, 2023 | ||
| CotheraBio develops innovative cancer therapies with a focus on translational oncology. It has developed its proprietary i-CR® technology platform, which is a powerful method for providing individualized drug screening and new drug development. The platform combines a high content screening system with the conditional reprogramming of primarycultured tumor cells, which enables the efficient and undifferentiated expansion of primary patient-derived tumor cells in vitro, while also preserving the tumor’s heterogeneity. | Venture - Series Unknown / Jan 02, 2021 | ||
| Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptorinhibitors and other products, for the treatment of advanced prostate cancer and breast cancer. | $40M / Series B / Jul 31, 2019 | ||
| Yuntai Network provides mobile Internet medical integrated service such as financial security and cloud hospital solutions for hospitals and medical authorities. Its products include pocket hospital and cloud hospital which provides intelligent guidance, appointment registration, queuing call number, and clinic room for patient, enabling hospitalsand patients to enjoy a one-stop mobile internet health management platform. | $14.5M / Series B / May 23, 2019 | ||
| Yao123.com is operates a similar integrated online-offline model. | $44.6M / Series B / Apr 27, 2019 | ||
| Suochen Information is a system software and hardware R&D and SAAS service provider, providing customers with product life cycle collaborative development system software and hardware, SAAS services. Products and services cover research and development frontier engineering, digital design and intelligent manufacturing. Customers are widelydistributed in heavy machinery, ground transportation, electronics, construction, aviation, aerospace, weapons, ships, optoelectronics, power equipment and other industries. | Series B / Feb 26, 2019 | ||
| Jekun Auto is an automobile maintenance service firm. The Group's business layout covers the entire automotive aftermarket, including auto beauty, maintenance, sheet metal painting, car modification, parts sales, business agency, auto insurance inquiry, road rescue, etc. The company was established in 2013 and is based in Guangzhou, China. | $14.8M / Series B / Jan 10, 2019 | ||
| Moviebook is a Chinese startup in the video recognition and online video technology areas. It is committed to developing video interaction platform of revolutionary significance and high commercial value. Driven by technology, its innovation is embracing the online video industry, and is opening a creative development path.Moviebook is based inBeijing, China. | $198.4M / Series D / Aug 07, 2018 | ||
| Svision is a healthcare start-up that develops and produces high-end ophthalmic imaging equipment. | $3.8M / Series A / Jun 29, 2018 | ||
| Abmart specializes in antibody customization and antibody-related services. | $2.8M / Series B / Jun 12, 2018 | ||
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Lang Sheng Investment invest in?
Lang Sheng Investment invests primarily in Health Care, Pharmaceutical and Medical startups, most often at Series B and Series A stage. Most of the 18 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Lang Sheng Investment last invest?
The most recent investment recorded for Lang Sheng Investment closed in Mar 2023. Shizune tracks 18 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
